Cell sourcing and culture conditions for fibrin-based valve constructs.

Cell sourcing for tissue-engineered heart valves remains a critical issue. In this work, human dermal fibroblasts (HDF) or porcine valve interstitial cells (PVIC) were entrapped in adherent fibrin disk constructs and harvested at 3 and 5 weeks. We compared the fibrin remodeling abilities of each cell type in Dulbecco's Modified Eagle's Medium (DMEM) and DMEM/F12 supplemented with transforming growth factor beta (TGF), and the response of PVIC to DMEM/F12 supplemented with fibroblast growth factor (FGF), a combination of FGF and TGF, and TGF with varying ascorbic acid (AA) concentrations. Culture media were supplemented with serum, insulin, AA, a fibrinolysis inhibitor, and antibiotics. DMEM maximized collagen and elastin deposition by HDF, while DMEM/F12 with FGF yielded the highest fibrin remodeling response by PVIC. HDF degraded fibrin slower than PVIC, and PVIC constructs had higher cellularity than HDF constructs in DMEM and DMEM/F12 at 3 weeks. FGF addition increased collagen content, collagen deposited per cell, and collagen as percentage of total protein compared to medium supplemented with TGF or TGF and FGF. AA addition increased collagen deposition by PVIC, but there was no dose dependence between 50 and 150 microg/mL AA. These results collectively show that PVIC are able to remodel fibrin faster and exhibit greater mechanical stiffening compared to HDF. Conditions for increased collagen deposition are also identified toward the engineering of valve constructs.

[1]  T. Tuan,et al.  In vitro fibroplasia: matrix contraction, cell growth, and collagen production of fibroblasts cultured in fibrin gels. , 1996, Experimental cell research.

[2]  H. Kagan,et al.  Lysyl oxidase: properties, regulation and multiple functions in biology. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[3]  R T Tranquillo,et al.  A fibrin-based arterial media equivalent. , 2003, Journal of biomedical materials research. Part A.

[4]  M. Butler,et al.  Profile of energy metabolism in a murine hybridoma: Glucose and glutamine utilization , 1994, Journal of cellular physiology.

[5]  K J Halbhuber,et al.  Complete dynamic repopulation of decellularized heart valves by application of defined physical signals-an in vitro study. , 2003, Cardiovascular research.

[6]  Michael S Sacks,et al.  The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. , 2005, Biomaterials.

[7]  F J Schoen,et al.  Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999. Tissue heart valves: current challenges and future research perspectives. , 1999, Journal of biomedical materials research.

[8]  Béla Suki,et al.  Mechanical and failure properties of extracellular matrix sheets as a function of structural protein composition. , 2008, Biophysical journal.

[9]  A. McCulloch,et al.  Heart valve and arterial tissue engineering , 2003, Cell proliferation.

[10]  Kristyn S Masters,et al.  Designing scaffolds for valvular interstitial cells: cell adhesion and function on naturally derived materials. , 2004, Journal of biomedical materials research. Part A.

[11]  Ž. Vujašković,et al.  TGF-beta and bFGF affect the differentiation of proliferating porcine fibroblasts into myofibroblasts in vitro. , 1999, Biomaterials.

[12]  H. Nair,et al.  Purification of Fibrinogen and Virus Removal Using Preparative Electrophoresis , 2001, Annals of the New York Academy of Sciences.

[13]  R. Superfine,et al.  Visualization and mechanical manipulations of individual fibrin fibers suggest that fiber cross section has fractal dimension 1.3. , 2004, Biophysical journal.

[14]  A. Ramamurthi,et al.  Towards tissue engineering of a composite aortic valve. , 2002, Biomedical sciences instrumentation.

[15]  M. Yacoub,et al.  Specific regional and directional contractile responses of aortic cusp tissue. , 2004, The Journal of heart valve disease.

[16]  Wiedenmann,et al.  Effects of exogenous zinc supplementation on intestinal epithelial repair in vitro , 2000, European journal of clinical investigation.

[17]  S. Hoerstrup,et al.  Tissue engineering of a bioprosthetic heart valve: stimulation of extracellular matrix assessed by hydroxyproline assay. , 1999, ASAIO journal.

[18]  D J Mooney,et al.  Engineering smooth muscle tissue with a predefined structure. , 1998, Journal of biomedical materials research.

[19]  A. Gotlieb,et al.  Advances towards understanding heart valve response to injury. , 2002, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[20]  Magdi H Yacoub,et al.  Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering. , 2002, The Journal of heart valve disease.

[21]  V. Corfield,et al.  Effects of cystine or glutamine restriction on human diploid fibroblasts in culture , 1978, In Vitro.

[22]  I Vesely,et al.  Aortic valve cusp microstructure: the role of elastin. , 1995, The Annals of thoracic surgery.

[23]  M. Butler,et al.  Glucose and glutamine metabolism of a murine B-lymphocyte hybridoma grown in batch culture , 1993, Applied biochemistry and biotechnology.

[24]  A. Grodzinsky,et al.  Fluorometric assay of DNA in cartilage explants using Hoechst 33258. , 1988, Analytical biochemistry.

[25]  A H Chester,et al.  Mitogenic and secretory responses of human valve interstitial cells to vasoactive agents. , 2000, The Journal of heart valve disease.

[26]  A. Lehninger.  Principles of Biochemistry , 1984 .

[27]  Diane Hoffman-Kim,et al.  Tricuspid valve biopsy: a potential source of cardiac myofibroblast cells for tissue-engineered cardiac valves. , 2003, The Journal of heart valve disease.

[28]  R T Tranquillo,et al.  Fibrin as an alternative biopolymer to type-I collagen for the fabrication of a media equivalent. , 2002, Journal of biomedical materials research.

[29]  Robert M Nerem,et al.  Porcine aortic valve interstitial cells in three-dimensional culture: comparison of phenotype with aortic smooth muscle cells. , 2004, The Journal of heart valve disease.

[30]  C K Breuer,et al.  Tissue engineering heart valves: valve leaflet replacement study in a lamb model. , 1995, The Annals of thoracic surgery.

[31]  Magdi H. Yacoub,et al.  The cardiac valve interstitial cell. , 2003, The international journal of biochemistry & cell biology.

[32]  F J Schoen,et al.  Future directions in tissue heart valves: impact of recent insights from biology and pathology. , 1999, The Journal of heart valve disease.

[33]  L. Leinwand,et al.  Valvular Myofibroblast Activation by Transforming Growth Factor-&bgr;: Implications for Pathological Extracellular Matrix Remodeling in Heart Valve Disease , 2004, Circulation research.

[34]  U A Stock,et al.  Tissue engineering of cardiac valves on the basis of PGA/PLA Co-polymers. , 2001, Journal of long-term effects of medical implants.

[35]  Diane Hoffman-Kim,et al.  Comparison of three myofibroblast cell sources for the tissue engineering of cardiac valves. , 2005, Tissue engineering.

[36]  R T Tranquillo,et al.  Enhanced fibrin remodeling in vitro with TGF-beta1, insulin and plasmin for improved tissue-equivalents. , 2002, Biomaterials.

[37]  Frederick J. Schoen,et al.  Early In Vivo Experience With Tissue-Engineered Trileaflet Heart Valves , 2000, Circulation.

[38]  K J Halbhuber,et al.  Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[39]  H. Scheld,et al.  Tissue Engineering of Heart Valves: Formation of a Three-Dimensional Tissue Using Porcine Heart Valve Cells , 2002, ASAIO journal.

[40]  H. Winkler,et al.  Rickettsia prowazekii requires host cell serine and glycine for growth , 1987, Infection and immunity.

[41]  A. Sterpetti,et al.  Basic fibroblast growth factor mediates carotid plaque instability through metalloproteinase-2 and -9 expression. , 2004, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[42]  H. Stegemann,et al.  Determination of hydroxyproline. , 1967, Clinica chimica acta; international journal of clinical chemistry.

[43]  T. Shih,et al.  Development of Intracranial Complications following Transoral Stab Wounds in Children , 2002, Pediatric Neurosurgery.

[44]  F J Schoen,et al.  Functional Living Trileaflet Heart Valves Grown In Vitro , 2000, Circulation.

[45]  Y. Jo,et al.  Tissue-Engineered Heart Valve Leaflets: An Effective Method for Seeding Autologous Cells on Scaffolds , 2000, The International journal of artificial organs.

[46]  J. Czernuszka,et al.  The effect of two types of cross-linking on some mechanical properties of collagen. , 1995, Bio-medical materials and engineering.

[47]  B J Messmer,et al.  Fibrin gel -- advantages of a new scaffold in cardiovascular tissue engineering. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[48]  C. Levene,et al.  ASCORBIC ACID AND COLLAGEN SYNTHESIS IN CULTURED FIBROBLASTS , 1975, Annals of the New York Academy of Sciences.

[49]  H. Kuramoto,et al.  Effects of serine and glycine on proliferation of an Ishikawa cell variant. , 1989, Journal of steroid biochemistry.

[50]  K. Paigen,et al.  A simple, rapid, and sensitive DNA assay procedure. , 1980, Analytical biochemistry.

[51]  F J Schoen,et al.  Tissue engineering of heart valves: in vitro experiences. , 2000, The Annals of thoracic surgery.

[52]  C. M. Agrawal,et al.  Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. , 1996, Biomaterials.

[53]  A H Chester,et al.  Receptor-mediated contraction of aortic valve leaflets. , 2000, The Journal of heart valve disease.

[54]  W. Clark.  Selective control of fibroblast proliferation and its effect on cardiac muscle differentiation in vitro. , 1976, Developmental biology.

[55]  H. Padh.  Cellular functions of ascorbic acid. , 1990, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[56]  Michael S. Sacks,et al.  A novel bioreactor for the dynamic flexural stimulation of tissue engineered heart valve biomaterials. , 2003 .

[57]  T C Flanagan,et al.  Living artificial heart valve alternatives: a review. , 2003, European cells & materials.

[58]  M. Yacoub,et al.  Phenotypic and functional characterization of interstitial cells from human heart valves, pericardium and skin. , 2000, The Journal of heart valve disease.

[59]  F. Grinnell,et al.  Fibronectin and fibrinolysis are not required for fibrin gel contraction by human skin fibroblasts , 1989, Journal of cellular physiology.

[60]  L. Reitzer,et al.  Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. , 1979, The Journal of biological chemistry.

[61]  B. Starcher,et al.  A ninhydrin-based assay to quantitate the total protein content of tissue samples. , 2001, Analytical biochemistry.

[62]  R. Tranquillo,et al.  ECM gene expression correlates with in vitro tissue growth and development in fibrin gel remodeled by neonatal smooth muscle cells. , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[63]  H M D William Willis,et al.  Founder's award , 1988 .

[64]  Robert T Tranquillo,et al.  Tissue-engineered valves with commissural alignment. , 2004, Tissue engineering.

[65]  Robert T Tranquillo,et al.  Elastic fiber production in cardiovascular tissue-equivalents. , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[66]  M. Swift,et al.  Growth of human skin fibroblasts in dialyzed fetal bovine serum , 2007, In Vitro.